Multiply Labs, a San Francisco-based company developing automated manufacturing systems to produce individualized drugs at scale, raised $20 million in a Series A funding. The round was led by Casdin Capital. The oversubscribed round brings Multiply Labs’ total funding raised to date to more than $25 million. It leverages automation to address the fundamental limitations…